Literature DB >> 15131013

Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals.

Kristine M Wiren1, Xiao-Wei Zhang, Amber R Toombs, Viera Kasparcova, Michael A Gentile, Shun-ichi Harada, Karl J Jepsen.   

Abstract

The androgen receptor (AR), as a classic steroid receptor, generally mediates biologic responses to androgens. In bone tissue, both AR and the estrogen receptor (ER) are expressed in a variety of cell types. Because androgens can be converted into estrogen via aromatase activity, the specific role of the AR in maintenance of skeletal homoeostasis remains controversial. The goal of this study was to use skeletally targeted overexpression of AR as a means of elucidating the specific role(s) for AR transactivation in bone homeostasis. Rat AR cDNA was cloned downstream of a 3.6-kb alpha1(I)-collagen promoter fragment and used to create AR-transgenic mice. AR-transgenic males gain less weight and body and femur length is shorter than wild-type controls, whereas females are not different. AR-transgenic males also demonstrate thickened calvaria and increased periosteal but reduced endosteal labeling by fluorescent labeling and reduced osteocalcin levels. High-resolution micro-computed tomography shows normal mineral content in both male and female AR-transgenic mice, but male AR-transgenics reveal a reduction in cortical area and moment of inertia. Male AR-transgenics also demonstrate an altered trabecular morphology with bulging at the metaphysis. Histomorphometric analysis of trabecular bone parameters confirmed the increased bone volume comprised of more trabeculae that are closer together but not thicker. Biomechanical analysis of the skeletal phenotype demonstrate reduced stiffness, maximum load, post-yield deflection, and work-to-failure in male AR-transgenic mice. Steady-state levels of selected osteoblastic and osteoclastic genes are reduced in tibia from both male and female transgenics, with the exception of increased osteoprotegerin expression in male AR-transgenic mice. These results indicate that AR action is important in the development of a sexually dimorphic skeleton and argue for a direct role for androgen transactivation of AR in osteoblasts in modulating skeletal development and homeostasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131013     DOI: 10.1210/en.2003-1016

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  31 in total

1.  Peripheral cannabinoid receptor, CB2, regulates bone mass.

Authors:  Orr Ofek; Meliha Karsak; Nathalie Leclerc; Meirav Fogel; Baruch Frenkel; Karen Wright; Joseph Tam; Malka Attar-Namdar; Vardit Kram; Esther Shohami; Raphael Mechoulam; Andreas Zimmer; Itai Bab
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

2.  Administration of saccharin to neonatal mice influences body composition of adult males and reduces body weight of females.

Authors:  Sebastian D Parlee; Becky R Simon; Erica L Scheller; Emilyn U Alejandro; Brian S Learman; Venkatesh Krishnan; Ernesto Bernal-Mizrachi; Ormond A MacDougald
Journal:  Endocrinology       Date:  2014-01-23       Impact factor: 4.736

3.  Estrogens, the be-all and end-all of male hypogonadal bone loss?

Authors:  M R Laurent; E Gielen; D Vanderschueren
Journal:  Osteoporos Int       Date:  2014-11-07       Impact factor: 4.507

Review 4.  Regulation of adult bone turnover by sex steroids.

Authors:  Baruch Frenkel; Albert Hong; Sanjeev K Baniwal; Gerhard A Coetzee; Claes Ohlsson; Omar Khalid; Yankel Gabet
Journal:  J Cell Physiol       Date:  2010-08       Impact factor: 6.384

5.  CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.

Authors:  Katherine J Motyl; Michelle Raetz; Srinivasan Arjun Tekalur; Richard C Schwartz; Laura R McCabe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-23       Impact factor: 3.619

6.  Bone vs. fat: embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts.

Authors:  Kristine M Wiren; Joel G Hashimoto; Anthony A Semirale; Xiao-Wei Zhang
Journal:  Bone       Date:  2011-06-17       Impact factor: 4.398

7.  Androgen receptor overexpression is neuroprotective in experimental stroke.

Authors:  Patricia Ayala; Masayoshi Uchida; Kozaburo Akiyoshi; Jian Cheng; Joel Hashimoto; Taiping Jia; Oline K Ronnekleiv; Stephanie J Murphy; Kristine M Wiren; Patricia D Hurn
Journal:  Transl Stroke Res       Date:  2011-04-15       Impact factor: 6.829

8.  Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA.

Authors:  Sanjeev K Baniwal; Omar Khalid; Donna Sir; Grant Buchanan; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Endocrinol       Date:  2009-04-23

9.  Inactivation of the androgen receptor in bone-forming cells leads to trabecular bone loss in adult female mice.

Authors:  Jorma A Määttä; Kalman G Büki; Kaisa K Ivaska; Vappu Nieminen-Pihala; Teresa D Elo; Tiina Kähkönen; Matti Poutanen; Pirkko Härkönen; Kalervo Väänänen
Journal:  Bonekey Rep       Date:  2013-11-06

10.  Androgen prevents hypogonadal bone loss via inhibition of resorption mediated by mature osteoblasts/osteocytes.

Authors:  Kristine M Wiren; Xiao-Wei Zhang; Dawn A Olson; Russell T Turner; Urszula T Iwaniec
Journal:  Bone       Date:  2012-08-14       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.